Literature DB >> 17508995

Polymorphisms of the dopamine D4 receptor gene (DRD4 VNTR) and cannabinoid CB1 receptor gene (CNR1) are not strongly related to cue-reactivity after alcohol exposure.

Esther van den Wildenberg1, Rob G J H Janssen, Kent E Hutchison, Gerard J P van Breukelen, Reinout W Wiers.   

Abstract

Polymorphisms in the D4 dopamine receptor gene (DRD4) and the CB1 cannabinoid receptor gene (CNR1) have been associated with a differential response to alcohol after consumption. The goal of the present study was to investigate whether heavy drinkers with these polymorphisms would respond with enhanced cue-reactivity after alcohol exposure. Eighty-eight male heavy drinkers were genotyped for the DRD4 variable number of tandem repeats (VNTR) [either DRD4 long (L) or short (S)] and the CNR1 rs2023239 polymorphism (either CT/CC or TT). Participants were exposed to water and beer in 3-minute trials. Dependent variables of main interest were subjective craving for alcohol, subjective arousal and salivary reactivity. Overall, no strong evidence was found for stronger cue-reactivity (= outcome difference between beer and water trial) in the DRD4 L and CNR1 C allele groups. The DRD4 VNTR polymorphism tended to moderate salivary reactivity such that DRD4 L participants showed a larger beverage effect than the DRD4 S participants. Unexpectedly, the DRD4 L participants reported, on average, less craving for alcohol and more subjective arousal during cue exposure, compared with the DRD4 S participants. As weekly alcohol consumption increased, the CNR1 C allele group tended to report more craving for alcohol during the alcohol exposure than the T allele group. The DRD4 and CNR1 polymorphisms do not appear to strongly moderate cue-reactivity after alcohol cue exposure, in male heavy drinkers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17508995     DOI: 10.1111/j.1369-1600.2007.00064.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  24 in total

1.  Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users.

Authors:  Joseph P Schacht; Kent E Hutchison; Francesca M Filbey
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

Review 2.  Endocannabinoid signalling in reward and addiction.

Authors:  Loren H Parsons; Yasmin L Hurd
Journal:  Nat Rev Neurosci       Date:  2015-09-16       Impact factor: 34.870

3.  Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala.

Authors:  Florence P Varodayan; Michal Bajo; Neeraj Soni; George Luu; Samuel G Madamba; Paul Schweitzer; Marisa Roberto
Journal:  Addict Biol       Date:  2016-01-20       Impact factor: 4.280

4.  Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype.

Authors:  Xiaomeng Xu; Uraina S Clark; Sean P David; Richard C Mulligan; Valerie S Knopik; John McGeary; James MacKillop; Jeanne McCaffery; Raymond S Niaura; Lawrence H Sweet
Journal:  Nicotine Tob Res       Date:  2014-03-22       Impact factor: 4.244

5.  Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study.

Authors:  Pushplata Prasad; Atul Ambekar; Meera Vaswani
Journal:  BMC Med Genet       Date:  2010-02-11       Impact factor: 2.103

Review 6.  A review of pharmacogenetic studies of substance-related disorders.

Authors:  Jermaine D Jones; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2015-03-18       Impact factor: 4.492

Review 7.  Pharmacogenetics of alcohol and alcohol dependence treatment.

Authors:  Henry R Kranzler; Howard J Edenberg
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

8.  Polymorphic variation in the dopamine D4 receptor predicts delay discounting as a function of childhood socioeconomic status: evidence for differential susceptibility.

Authors:  Maggie M Sweitzer; Indrani Halder; Janine D Flory; Anna E Craig; Peter J Gianaros; Robert E Ferrell; Stephen B Manuck
Journal:  Soc Cogn Affect Neurosci       Date:  2012-02-15       Impact factor: 3.436

9.  Real-time assessment of alcohol craving and naltrexone treatment responsiveness in a randomized clinical trial.

Authors:  Robert Miranda; Hayley Treloar Padovano; Joshua C Gray; Stephanie E Wemm; Alexander Blanchard
Journal:  Addict Behav       Date:  2018-01-10       Impact factor: 3.913

10.  Molecular genetics of alcohol dependence and related endophenotypes.

Authors:  Yann L Strat; Nicolas Ramoz; Gunter Schumann; Philip Gorwood
Journal:  Curr Genomics       Date:  2008-11       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.